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Abstract 
The paper highlights current status of knowledge on Indian medicinal plant species 
used in organized systems of medicine, ethnomedicine and modern medicine. It 
reviews all-pervasive concern of medicinal plants including role of institutions, 
organizations, government bodies, rules enforced by them, difficulties in field studies, 
etc. Current needs to reach sustainable development and their conservation are put 
together pertinently revealing the state of art of Indian medicinal plants. This review 
will help guide others interested in medicinal plant research, apart from ecologist, 
traders and industrialists.  
 
1. Introduction 
All human societies showed profound interest 
on utilization as well as conservation of biodiversity 
in sustainable manner to which India is no 
exception. India has two mega centers of 
biodiversity especially in plant species viz., North 
eastern Himalayan region and Western Ghats. 
Indian forests are rich in medicinal plant species 
with a wide spectrum of healing properties. The 
Traditional Indian System of Medicine has been 
therefore well developed due to this richness of 
bio-resources. Interest on indigenous health 
traditions and demand for herbal remedies are 
undoubtedly discernible trends worldwide. These 
have culminated into over exploitation of our 
natural bio-resources leading some important 
medicinal plant species to rarity, extinction and 
endangered state. It, therefore, appears that current 
concern must to be addressed to the protection of 
species from over-exploitation and also enriching 
the biodiversity. It is therefore, desirable to strive 
towards these goals and lay emphasis on:  i) 
Characterization of medicinal plants, ii) Assessing 
magnitude and distribution of medicinal plant 
diversity in different states, iii) Assessment of loss 
of medicinal plant diversity, iv) Monitoring and 
maintenance of inventory of medicinal plant 
diversity,      v) Effective information management 
and communications, vi) Assessment of economic 
values of medicinal plant diversity, vii) Measures for 
conservation and sustainable use of its components.  
India’s biodiversity is mainly distributed in Western 
Ghats, Andaman and Nicobar Islands, 
Northeastern India and the Himalayan region with 
about 80% of the global biodiversity. Indian sub-
continent is enriched with about 45,000 plant 
species of which nearly 18,000 are flowering plants.  
This vast degree of diversity is correlated to the 
greatly divergent ecosystems and altitudinal 
variations. The agro-biodiversity particularly in 
India is distributed in eight diverse phyto-
geographical and 15 agro-ecological regions. The 
range of distribution of these plants differs from 
the wet evergreen forest in the Western Ghats to 
the Alpine scrubs of Himalayas, from the arid 
deserts of Rajasthan to the mangroves along the 
east coast, from the vast deciduous forests of 
Deccan to the Sholas of the high ranges, from the 
swamps of the Ganges to the moss laden tree 
trunks of the Silent valley. The indigenous diversity 
of the plant species of medicinal and aromatic value 
in the region is is also unparellel. This is reflected 
from the Arogyapacha (Trichopus zeylanicus) of the 
Agastiar Hills to the Salaam panja of the Himalayas, 
from the tiny Drosera of the Sholas to the huge 
Dipterocarps of the Western Ghats, from the 
xerophytic Aloes to the marshy land Brahmis, from 
the wild turmerics to the cultivated peppers (Ved et 
al.)1 There is 1500 species of codified knowledge. 
These are used in organized system of medicine like 
Ayurveda, Unani and Siddha. About 3000 species 
are available from the empirical knowledge. These 
are used as ethnomedicine. Their information is 
orally passed over generations. Nearly 700 species 
have been investigated pharmacologically and 
chemically. These are used in modern medicine. 
(Ved Prakash)2. These figures have now obviously 
increased. Plants and plan-based products have 
been used traditionally by the inhabitants of India 
from the time immemorial. Several references of 
healing properties of plants are stated in Rigveda 
(400-1500 B.C.) Atharvaveda (1500 B.c.), 
Upnishada (1000 B.C.), Mahabharta and Puranas 
(700-400 B.C.).  Charaka Samhita and Susruta 
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Samhita are other two monumental works (1000 
B.C. to 600 B.C.). The invasions of Greeks and 
Muslims rulers influenced a lot in the use of plant 
based medicines. The rise of Buddhism also 
boosted to the study of herbal medicines in olden 
days. India has thus developed Ayurveda and Unani 
two important systems widely practiced in present 
Indian system of medicines. Many medicinal plants 
are advised in these systems, which are naturally 
distributed in India. This discloses the unique 
position of India in the utility of medicinal plants 
for long past. Utilization of our national heritage of 
medicinal plant resources should, therefore, be 
managed in such way that it must be aimed at 
conserving our bio-resources. It should divulge the 
maximum potential of the resources. This is dilated 
in the following.  
 
2. Discussion 
 The importance of medicinal plant is well 
known worldwide. Nevertheless, work on 
biodiversity on these received much less attention 
as compared to the food plant species. Commercial 
utilization including cultivation is a new 
phenomenon in medicinal plants. The recent trend 
of green chemistry of herbal remedies has caused a 
renaissance and rejuvenation in traditional systems 
of medicine. Demand for the herbal products is 
increasing worldwide. This trend has resulted into 
over-exploitation of the natural resources. It is now 
imperative to lay emphasis on the following 
activities:  
 
Characterization of medicinal plants 
In case of medicinal plant improvement, 
quality in terms of secondary metabolites is 
evaluated viz., alkaloid, steroid or essential oil 
production etc., which is not apparently dependent 
on morphological characters. Mostly the function 
of these compounds and their benefit to the plants 
are unearthed. Secondary metabolites occur in 
specific plants or groups of plants and are an 
expression of the particular species they are not 
necessarily produced under all conditions 
(Dewick,)3. Therapeutic value, therefore, is 
governed mostly by the secondary metabolites. It is 
an important factor in addition to yield in medicinal 
plants. Mode of inheritance of chemical 
constituents is hence very important in case of 
medicinal plants. Morphological characters are 
sometimes misleading and hence information on 
correlation between different morphological 
characters with yield and quality would be of great 
significance in medicinal species. Selection criteria 
and all the characterization objectives should 
therefore be directed so that these would enhance 
the total secondary metabolite content and 
production in medicinal plants. Simple introduction 
of a species for successful cultivation in a new 
habitat and environmental conditions may be 
misleading sometimes and futile due to chemical 
changes and infra-specific chemical modifications. 
These changes or modifications take place due to 
changed ecological and geographical situations 
(Tetenyi )4.  
Characterization of the germplasm at and 
below specific levels in medicinal plants would be 
hence significantly essential and unparallel for the 
selection of the right plant type having desired 
attributes or quality for cultivation. This would also 
enhance sustainable utilization of the medicinal 
plant diversity. Investigation on characterization in 
many medicinal plants carried out in India exhibited 
a wide spectrum of variability. In isabgol (Plantago 
ovata) a number of workers investigated plant 
variability within the germplasm, stability of the 
available lines, etc., (Bhagat,)5, (Jindla et al.)6, 
(Sangan et al.)7, (Godawat)8, (Lal et al.)9, Germplasm 
studies conducted with 70 cultivars of isabgol 
revealed highest heritability in spike length, seed 
yield number of branches, spike number and length. 
These directly contributed to yield (Bhagat) 10, In 
kalmegh, (Andrographis paniculata) cytotypes were 
reported from different collections of India and 
Bangladesh (Roy and Datta)11 Genetic divergence 
study conducted by   (Mishra et al.,)12 in 
Ashwagandha, (Withania somnifera), identified 
different parental lines within the available 
germplasm. In Safed musli (Chlorophytum 
borivillianum), work carried out at different, All India 
Coordinated Research Project on Ethnobiology 
(AICRPE)13, centres showed the variability in 
abundance in the available germplasm (Jat and 
Sharma)14; (Geetha and Maiti)15, (Bhagat and 
Jadeja)16. Use of different molecular marker tools 
such as isozyme, RAPD, AFLP analysis, etc., for 
evaluation of variability within the species or 
relatedness between the species were also used in 
medicinal plants e.g. Plantago ovata, (Pramanik et 
al.)17, Andrographis paniculata (Padmesh, et al.)18. 
 
Assessment of magnitude and distribution of 
medicinal plant diversity in different states 
Knowing of magnitude of diversity in 
medicinal species is crucial for fixation of its 
conservation, utilization and management strategies. 
This data bank will help safeguard sustainable 
utilization regulating the harvesting as per 
magnitude of species population in a given 
ecosystem. The magnitude of diversity in medicinal 
species can be observed by different scales, 
nevertheless the most important is the species 
diversity. About 141 endemic genera. 2532 endemic 
species are distributed in Himalayas, 1788 species in 
peninsular region and 185 species in the Andaman 
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and Nicobar islands. More than 7500 plant species 
are referred in Indian folklore. Only about 1700 
plant species are mentioned in the documented 
form of ancient or past literature. A precise and 
accurate number of the total medicinally important 
species distributed in the area is difficult due to the 
difficulty in correlating the local names used in the 
traditional systems to the scientific names. Hence a 
national coordinated network programme is 
required to interlink all the traditional systems of 
medicines and document the species used in 
various systems and their scientific names with their 
distributional patterns to avoid synonyms, 
duplications and misnomer, etc., This is a common 
fact in case of Indian medicinal plant species 
because varied cultures, languages and dialects. 
Different vegetable sources provide the same mode 
of action against ailment and hence could be 
employed as per the availability of the species 
regionally. This will help to avoid over-exploitation 
of certain species from some regions. If concise 
information is made available in this respect we can 
avoid drug adulterations and check escalated 
demand and prices of certain raw drugs. Well 
known example in this case is the use of species of 
Chlorophytum and Asparagus as a source of raw drug 
Safed musali (Patil)19, Valerian (Ved 
Prakash)20,Tukmaria (Shah)21 and Daruhridra where 
a number species like Berberis, Coscinium, etc. are 
used.  
Assessment of loss of medicinal plant diversity 
Investigations on assessment loss of medicinal 
plant diversity will help the understanding of forces 
of interference, needs for its re-instatement, 
management and execution of different creative 
measures for its sustainable utilization and 
conservation. Biodiversity loss is a common 
phenomenon throughout the world. But the pace at 
which the species experience the problem of 
extinction is alarming. The biodiversity loss because 
of urbanization, industrialization, etc., has become 
common phenomenon in developing countries. 
This has bearing on medicinal plant diversity also. 
In addition, the medicinal plants as such are facing 
another dimension of loss because of indiscriminate 
harvesting to meet the increased demand of the 
herbal drugs. This has culminated in unsustainable 
harvesting in view of quantity as well as time and 
method of harvesting leading to overexploitation. It 
is possible to categorise the medicinal plant 
diversity loss into: (i) The global phenomenon of 
habitat loss. (ii) The overexploitation of medicinal 
plants. Population explosion, expansion of 
agricultural land, industrialization, etc. caused a vast 
destruction in the forest area. This automatically 
threatened the survival of many of the plant species 
that they shelter. Globally about 10% of world flora 
may be threatened (Cody) 22 According to the 1997 
IUCN Red list; about 12.5 % of World’s flora is 
facing the threat of extinction. The same or 
probably more serious threat is there for the 
medicinal plants. Using the current global rate of 
species extinction, about 10-12 % of the medicinal 
plants of India (i.e. about 800-1000 species) are 
likely to be threatened. About 95% of medicinal 
plants in trade in India are obtained from the wild. 
The rising demands for natural products such as 
herbal medicines, cosmetics, food supplements and 
health products, etc. in the national and 
international markets caused mining of medicinal 
plant species from the wild. High consumption of 
wild flora and their destructive collection methods 
caused some of the species vulnerable to the 
survival of this invaluable wealth in nature. It is 
estimated that over 70% of the plant collection 
involve destructive methods. The quantity of the 
collected material from the wild often becomes the 
focus of criticism at the cost of the time and 
method of harvesting. The methods, time and 
quantity of collections from a particular area are 
also critical for depleting biodiversity or its total 
loss. On account ruthless collections of raw 
material of a species from its natural habitat, 
population size will decline and small population 
attracts less pollinators and have low reproductive 
success (Jennersten)23. Unbalanced male female 
ratios of a dioecious species also have bearing on 
the population growth. Life spans of species matter 
since short-lived species need lesser time for 
extinction if it is overexploited.  
 
Monitoring, maintenance and inventory of 
medicinal plant diversity 
Convention on Biological Diversity (CBD)24, 
raised the need for monitoring and maintenance of 
diversity inventory. The CBD is a landmark in 
protecting environment and its development field, 
since it takes, for the first time, a comprehensive 
rather than a sectorial approach to the conservation 
of the Earth’s biodiversity and sustainable use of 
bioresources with benefit sharing. India is signatory 
of the (CBD)24 and therefore, responsible to 
promote the cause of protecting biodiversity for the 
posterity of the human race. One of the major 
recommendations of the CBD is maintenance of 
biodiversity inventory. Maintenance of medicinal 
plants inventory and its monitoring on a regular 
basis would need serious attention for taking 
appropriate steps in maintenance and conservation 
of depleting populations of species or species 
groups with high demand. Occurrence and diversity 
of medicinal species is considerably diverse and 
unparallel in India. Biodiversity inventorying 
includes data on surveying, sorting, cataloging, 
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quantifying and mapping of individuals, species, 
populations, habitat, biotypes, ecosystem, etc. 
Repetitive inventorying over time will help monitor 
the biodiversity at a particular locality it provides 
information on changes occurring in biodiversity 
over time. Data from these activities will aid in 
providing information for policy and management 
goals for land used, trade, environmental impact 
assessment and conservation. Inventories of species 
and its population of medicinal species could be 
employed efficiently and prioritize research 
objectives in these group of species. Inventorying 
biodiversity includes physical census and remote 
sensing coupled with ground truth data.  
Enumeration and documentation of the 
species diversity within the geographic area of the 
country would be very important considering the 
new developments in the sovereignty of the 
country on its germ-plasm resources. This is so 
because biological entities are not restricted by 
political boundaries National and international 
agreements are required where there is sharing of 
expertise, facilities and information for a full-proof 
data base under these circumstances. Developing a 
Traditional Knowledge Digital Library (TDKL) to 
save India’s ancient knowledge is one attempt of 
documentation of usages of medicinal plant 
diversity. This is because of patent claims which 
may develop worldwide for non- original 
inventions based on different Indian medicinal 
species. 
 
Effective information management and 
communications 
The biological and genetic resources are now 
conceived as natural resources with potential 
economic value after CBD establishment. Other 
such international agreements. viz., the Convention 
on International Trade in Endangered Species 
(CITES), Chapter 15 0f Agenda 21, the World 
heritage Convention and the Global Biodiversity 
Strategy, etc., also suggested the effective 
management , organization and use of biodiversity 
information. Information Management and 
communication makes a strong footing while taking 
any decisions for protections of various concerns 
about biodiversity conservation and its utilization. 
In India, though information management and its 
dissemination through effective communication 
system is recognized as an essential government 
activity, development and use of medicinal plants 
biodiversity information has not received sufficient 
importance. The efforts in this area have been 
undertaken by scientific government bodies e.g. 
Botanical Survey of India. AICRPE (1992-1998) 
reported 8000 wild plant species useful by tribal for 
their healthcare, of which 2000 are with new claims 
and worthy of scientific scrutiny, the indigenous 
knowledge thus provides fuel for biologically active 
molecules. Creation and broadening of the 
authentic medicinal plant biodiversity information 
data base and its use by the various stakeholders are 
real challenge and needs attention of all 
stakeholders. While striving towards this goal, it is 
necessary to network the information data base of 
the stakeholders of medicinal plants users and 
producers. However, before switching over to this 
task, herculean task should be taken for the 
formulation of methodologies and data 
organizations.  
 
Assessment of economic values of medicinal 
plant diversity 
The turn over of Indian herbal industry is estimated 
to be around 4000 crore per annum. The current 
use of medicinal plant resources on the basis of 
market signals is, however, inefficient and 
inadequate. Nearly 500 plant species are used by the 
pharmaceutical industry in India. Majority of the 
medicinal plants, especially medicinal tree species, 
are presently collected from the wild. Recently, 
utilization of medicinal plants has increased 
multifold due to ever increasing market of herbal 
industry. Medicinal plant cultivation is 
comparatively new phenomenon. Introduction of a 
new species may be in high demand; however, 
profitability of the species may be very low. Only a 
few medicinal species are under cultivation. 
 
Measures for conservation and sustainable use 
of its components 
Some conservation strategies have been adopted by 
the government and non-governmental 
organizations. Government of India has published 
a list of plants that are prohibited from trade by 
collection from nature considering the vulnerability 
of some medicinal plant species in nature. (Table-I) 
Still we are not convinced about their correct status 
of danger. It is worth to note that while developing 
curricula for tertiary education, due attention is 
sought for avoiding rare threatened plant species 
from wild. This is so since the maximum number 
of medicinal plants species used in trade is hailed 
from wild it is, therefore, necessary to have 
preference to examine commercialization of such 
taxa.   
 
List-I: Prohibited Medicinal Taxa: Aconitum sp., Aquilaria 
malaccensis, Coptis teeta, Coscinium fenastratum, Cycas beddomei, 
Dactylorhiza hatagirea, Dioscorea deltoidea, Euphorbia sp., Frerea 
indica, Gnetum sp., Gentiana kurroo, Kaempferia galanga, Nepenthes 
khasiana, Orchidaceae sp., Panax paeudoginseng, Paphiopedilium sp., 
Picrorhiza kurroo,  Pterocarpus marsupium, Rauvolfia serpentina, 
Renathera imschootiana, Swertia chirata, Taxus wallichiana, Vanda 
coerulea, etc,. 
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List-II:  Medicinal Species Commercially Unexploited: Abrus 
precatorius, Argeria nervosa, Bacopa monnieri, Boerhavia diffusa, 
Cassia sophera, Centella asiatica, Chlorophytum arundinaceum, 
Cissampelos pariera, Cissus quadrangularis, Clitoria ternatea, 
Convolvulus microphyllus, Costus speciosus Curculigo orchioides, 
Curcuma zedoaria Cynadon dactylon, Cyperus rotundus, Datura sp. 
Desmodium gangeticum, Eclipta alba, Evolvulus alisnoides, 
Gymnema sylvestris, Hemidesmus indicus, Hygrophila auriculata, 
Indigofera tinctoria, Leucas aspera, Leptadaenia reticulata, Mimosa 
pudica, Paedaria foetida, Pedalium murex, Plumbago zeylanica, Ruta 
graveolens, Sida sp. Smilax zeylanica, Solanum nigrum, Solanum 
surrettense, Solanum viarum, Spilanthus acmella, Tylophora indica, 
Urginia indica, Vernonia anthelmintica, Vitex negundo.          
 
The CBD also decided to implement provision 
for the conservation and sustainable utilization on 
biodiversity. Realizing sovereign right of the States 
to use there own biological resources, The CBD 
desires the parties to facilitate access to genetic 
resources by other parties for environmentally 
sound purposes subject to national legislation and 
on mutually agreed upon terms (cf. Articles 3 &15 
of CBD). Article 8 (i) of Convention of Biological 
Diversity (2001) recognizes contributions of local 
and indigenous communities to the conservation 
and sustainable utilization of biological diversity 
through traditional practices, knowledge and 
innovations. It provides for equitable sharing of 
benefits with such people arising from the 
utilization of their knowledge, practices and 
innovations. It is through Intellectual Property 
Rights (IPR) and particularly patents that control an 
ownership over traditional knowledge are being 
usurped by commercial interest (Pushpangandan 
and Kumar)25. Benefit sharing with Kani tribe on 
1:1 ratio is a model given by TBGRI and widely 
accepted (Puhpangandan and Kumar)25. Earlier to 
these agreements, there was no separate policy or 
regulation to facilitate conservation of medicinal 
species in India. Their conservation was chiefly 
covered under the forest Act and Wild Life 
Protection Act (1972). It was implemented by the 
State Forest Department and Indian Government’s 
Directorate of Wild Life Preservation. The central 
Government has brought Biological Diversity Act, 
2002 after CBD agreement. It has following 
functions: (i) to regulate access to biological 
resources of the country with the purpose of 
securing equitable share in benefits arising out of 
the use of biological resources and associated 
knowledge relating to biological resources, (ii) to 
conserve an sustainable use of biological diversity, 
(iii) to respect and protect knowledge of local 
communities related to biodiversity, (iv) to secure 
sharing of benefits with local people as conservers 
of biological resources and holders of knowledge  
and information relating to the use of biological 
resources. (v) conservation and development of 
areas of important from the standpoint of 
biological diversity heritage sites, (vi) protection 
and rehabilitation for threatened species, (vii) 
involvement of institutions of State government in 
the broad scheme for the implementation of the 
Biological Diversity Act through constitution of 
committees. But the idea of sustainable harvesting 
is greatly challenged by the lack of information of 
the life cycle, regeneration habit, reproductive 
biology, etc., of many of these plants. So serious 
efforts are required in this direction especially by 
the floral biologist also and the information 
collected thus should be shared with the collectors 
for the development of a sustainable collection 
parameters.    
In situ conservation project for the 
conservation of medicinal species was started in  
the States of Karnataka, Kerla and Tamil Nadu 
involving the State Forest Departments, research 
institutes in collaboration with FRLHT 
(Foundation for Revitalization of Local Health 
Traditions-A Bangalore based NGO group) in 1993. 
It was sponsored by Government of India. This 
developed a network of Medicinal plant 
Conservation Sites (MPCA), Medicinal Plant 
Conservation Parks (MPCP) and Medicinal Plant 
Development Sites (MPDA). Indigenous societies 
have their own ways and means for the 
conservation of bio-resources. One of such 
conservation practices is the ‘Sacred groves’. These 
are areas which are devoted to Gods and are strictly 
protected from human interference (cf. Vartak and 
Gadgil; Gadgil and Vartak,)27, It can be considered 
as the first human effort for the in situ,) 
conservation of biodiversity. But in present era, 
these great traditions are also facing a lot of threats 
because of the change in values, living styles and 
acculturation etc., and numbers of such in situ 
conservation sites are declining. This type of our 
cultural trends must be recognized and should pay 
attention towards hardness for the continuation of 
preservation of varied cultures and ecosystems. 
Seed gene banks, field gene banks, in vitro gene 
banks, herbal and botanical gardens, etc., are 
working for ex situ conservation. National Medicinal 
Plant Board (NMPB) through State Medicinal Plant 
Board (SMPB) promotes medicinal plant 
cultivation of selected species by providing 
monitory supports and marketing facilities. The 
major disadvantage of the ex situ conservation is the 
lack of natural evolution within the conserved 
materials. This problem can be partially resolved by 
linking ex situ intervention to in situ program 
wherever, feasible. 
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3. Concluding Remarks 
The strategies for sustainable utilization of our 
medicinal species may be summarize in a nutshell:  
a) Collection of critically endangered species 
and sustainable harvesting from the wild should be 
strictly banned from the trade for the certain period. 
It requires a full-hearted co-operation of the Forest 
Departments and the local human societies. 
Benefits accrued from such attempts should be 
shared with the local societies as well.   
b) Endeavors to evaluate the threat status of 
different enlisted medicinal plants should be 
appreciated in order to prioritize the plants to be 
selected for immediate care. People’s participatory 
program can be included for this study as the local 
people are the factual information source for 
obtaining the clear idea of the present and past 
distribution of a particular species at a particular 
locality. This information should be complemented 
with the information gained through from remote 
sensing.  
c) Species with medicinal significance under 
high demand and whose demand is ascertained 
stable and also under the threat category has to be 
given prime importance for future investigations. 
d) Integration should be practiced between 
food crops and medicinal plant cultivation, 
wherever possible. 
e) Net working system involving public and 
private institutions should be adopted so that there 
is complete linkage. Mass cultivation projects 
funded by industries on marginal lands with the 
available agro-techniques so as to stabilize the 
supply regularize trade and quality material.  
f) Research program should be started from 
for those species whose regenerative capacity with 
the available material is very poor and are little 
known for their biology.  
g) Strict observation of laws should be made 
by the conventions, acts, etc. from time to time.  
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